SCNINasdaq Israel
Market cap
$1.230 M
$0.25 -5.22%
Close of 7 Aug 2026
Revenue
$1.31M
#3480 by revenue
Earnings
-$8.31M
Loss-making
Shares outstanding
13,872,899,584
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Scinai Immunotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.